WSA
BCRX icon

Wall Street Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History

Wall Street Associates’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-56,269
Closed -$641K – 301
2015
Q3 		$641K Sell
56,269
-6,800
-11% -$77.5K 0.12% 197
2015
Q2 		$942K Buy
+63,069
New +$942K 0.09% 212